000 | 01847 a2200565 4500 | ||
---|---|---|---|
005 | 20250515052507.0 | ||
264 | 0 | _c20070403 | |
008 | 200704s 0 0 eng d | ||
022 | _a0968-0896 | ||
024 | 7 |
_a10.1016/j.bmc.2006.12.029 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMatulenko, Mark A | |
245 | 0 | 0 |
_a4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry _cFeb 2007 |
||
300 |
_a1586-605 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenosine Kinase _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMorpholines |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aProtein Conformation |
650 | 0 | 4 |
_aPyrimidines _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aPaight, Ernest S | |
700 | 1 | _aFrey, Robin R | |
700 | 1 | _aGomtsyan, Arthur | |
700 | 1 | _aDiDomenico, Stanley | |
700 | 1 | _aJiang, Meiqun | |
700 | 1 | _aLee, Chih-Hung | |
700 | 1 | _aStewart, Andrew O | |
700 | 1 | _aYu, Haixia | |
700 | 1 | _aKohlhaas, Kathy L | |
700 | 1 | _aAlexander, Karen M | |
700 | 1 | _aMcGaraughty, Steve | |
700 | 1 | _aMikusa, Joseph | |
700 | 1 | _aMarsh, Kennan C | |
700 | 1 | _aMuchmore, Steven W | |
700 | 1 | _aJakob, Clarissa L | |
700 | 1 | _aKowaluk, Elizabeth A | |
700 | 1 | _aJarvis, Michael F | |
700 | 1 | _aBhagwat, Shripad S | |
773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 15 _gno. 4 _gp. 1586-605 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2006.12.029 _zAvailable from publisher's website |
999 |
_c16763977 _d16763977 |